Currently, there is no specific treatment targeting rimmed vacuoles. Management generally focuses on treating the underlying condition. For example, in the case of IBM, immunosuppressive therapies may be used, although they are often of limited effectiveness. Research into therapies that can enhance autophagic pathways or reduce the accumulation of misfolded proteins is ongoing.
